KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zimmer Biomet Holdings (ZBH) Operating Expenses (2016 - 2025)

Zimmer Biomet Holdings (ZBH) has 17 years of Operating Expenses data on record, last reported at $2.1 billion in Q4 2025.

  • For Q4 2025, Operating Expenses rose 27.84% year-over-year to $2.1 billion; the TTM value through Dec 2025 reached $7.1 billion, up 11.58%, while the annual FY2025 figure was $7.1 billion, 11.58% up from the prior year.
  • Operating Expenses reached $2.1 billion in Q4 2025 per ZBH's latest filing, up from $1.6 billion in the prior quarter.
  • Across five years, Operating Expenses topped out at $2.1 billion in Q4 2025 and bottomed at $935.4 million in Q3 2021.
  • Average Operating Expenses over 5 years is $1.6 billion, with a median of $1.6 billion recorded in 2023.
  • The widest YoY moves for Operating Expenses: up 111.59% in 2021, down 42.62% in 2021.
  • A 5-year view of Operating Expenses shows it stood at $1.6 billion in 2021, then increased by 12.78% to $1.9 billion in 2022, then decreased by 14.43% to $1.6 billion in 2023, then grew by 3.05% to $1.6 billion in 2024, then increased by 27.84% to $2.1 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Expenses were $2.1 billion in Q4 2025, $1.6 billion in Q3 2025, and $1.8 billion in Q2 2025.